
Quality of life outcomes in APOLLO, the phase 3 trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis
Obici, Laura, Berk, John L., González-Duarte, Alejandra, Coelho, Teresa, Gillmore, Julian, Schmidt, Hartmut H.-J., Schilling, Matthias, Yamashita, Taro, Labeyrie, Céline, Brannagan, Thomas H., AjrouJournal:
Amyloid
DOI:
10.1080/13506129.2020.1730790
Date:
March, 2020
Fichier:
PDF, 1.88 MB
2020